| Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy JH Elliott, F Wightman, A Solomon, K Ghneim, J Ahlers, MJ Cameron, ... PLoS pathogens 10 (11), e1004473, 2014 | 556 | 2014 |
| Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2 … P Cahn, JS Madero, JR Arribas, A Antinori, R Ortiz, AE Clarke, CC Hung, ... The Lancet 393 (10167), 143-155, 2019 | 406 | 2019 |
| Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence GE Hartley, ESJ Edwards, PM Aui, N Varese, S Stojanovic, J McMahon, ... Science immunology 5 (54), eabf8891, 2020 | 296 | 2020 |
| Short-term administration of disulfiram for reversal of latent HIV infection: a phase 2 dose-escalation study JH Elliott, JH McMahon, CC Chang, SA Lee, W Hartogensis, N Bumpus, ... The lancet HIV 2 (12), e520-e529, 2015 | 260 | 2015 |
| Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority … JM Molina, K Squires, PE Sax, P Cahn, J Lombaard, E DeJesus, MT Lai, ... The lancet HIV 5 (5), e211-e220, 2018 | 214 | 2018 |
| Pharmacy adherence measures to assess adherence to antiretroviral therapy: review of the literature and implications for treatment monitoring JH McMahon, MR Jordan, K Kelley, S Bertagnolio, SY Hong, CA Wanke, ... Clinical Infectious Diseases 52 (4), 493-506, 2011 | 194 | 2011 |
| Long-term virological outcomes of first-line antiretroviral therapy for HIV-1 in low-and middle-income countries: a systematic review and meta-analysis TS Boender, KCE Sigaloff, JH McMahon, S Kiertiburanakul, MR Jordan, ... Clinical Infectious Diseases 61 (9), 1453-1461, 2015 | 177 | 2015 |
| Viral suppression after 12 months of antiretroviral therapy in low-and middle-income countries: a systematic review JH McMahon, JH Elliott, S Bertagnolio, R Kubiak, MR Jordan Bulletin of the World Health Organization 91, 377-385, 2013 | 165 | 2013 |
| Monkeypox infection presenting as genital rash, Australia, May 2022 Y Hammerschlag, G MacLeod, G Papadakis, AA Sanchez, J Druce, ... Eurosurveillance 27 (22), 2200411, 2022 | 158 | 2022 |
| BET inhibition blocks inflammation-induced cardiac dysfunction and SARS-CoV-2 infection RJ Mills, SJ Humphrey, PRJ Fortuna, M Lor, SR Foster, GA Quaife-Ryan, ... Cell 184 (8), 2167-2182. e22, 2021 | 147 | 2021 |
| Integrated immune dynamics define correlates of COVID-19 severity and antibody responses M Koutsakos, LC Rowntree, L Hensen, BY Chua, CE Van De Sandt, ... Cell Reports Medicine 2 (3), 2021 | 136 | 2021 |
| The HIV care cascade: a systematic review of data sources, methodology and comparability NA Medland, JH McMahon, EPF Chow, JH Elliott, JF Hoy, CK Fairley Journal of the International AIDS Society 18 (1), 20634, 2015 | 127 | 2015 |
| Barriers and strategies to achieve a cure for HIV MC Pitman, JSY Lau, JH McMahon, SR Lewin The Lancet HIV 5 (6), e317-e328, 2018 | 119 | 2018 |
| Broad activation of latent HIV-1 in vivo K Barton, B Hiener, A Winckelmann, TA Rasmussen, W Shao, K Byth, ... Nature communications 7 (1), 12731, 2016 | 90 | 2016 |
| Poverty, hunger, education, and residential status impact survival in HIV J McMahon, C Wanke, N Terrin, S Skinner, T Knox AIDS and Behavior 15 (7), 1503-1511, 2011 | 83 | 2011 |
| Remdesivir for the treatment of Covid-19-preliminary report JH McMahon, A Udy, AY Peleg The New England journal of medicine 383 (10), 992-993, 2020 | 81 | 2020 |
| HIV drug resistance early warning indicators in cohorts of individuals starting antiretroviral therapy between 2004 and 2009: World Health Organization global report from 50 … DE Bennett, MR Jordan, S Bertagnolio, SY Hong, G Ravasi, JH McMahon, ... Clinical infectious diseases 54 (suppl_4), S280-S289, 2012 | 77 | 2012 |
| Update on World Health Organization HIV drug resistance prevention and assessment strategy: 2004–2011 MR Jordan, DE Bennett, MA Wainberg, D Havlir, S Hammer, C Yang, ... Clinical infectious diseases 54 (suppl_4), S245-S249, 2012 | 75 | 2012 |
| Concomitant medication polypharmacy, interactions and imperfect adherence are common in Australian adults on suppressive antiretroviral therapy KJ Siefried, L Mao, LA Cysique, J Rule, ML Giles, DE Smith, J McMahon, ... Aids 32 (1), 35-48, 2018 | 74 | 2018 |
| Repeated assessments of food security predict CD4 change in the setting of antiretroviral therapy JH McMahon, CA Wanke, JH Elliott, S Skinner, AM Tang JAIDS Journal of Acquired Immune Deficiency Syndromes 58 (1), 60-63, 2011 | 65 | 2011 |
Sharon R. LewinDoherty Institute在 unimelb.edu.au 的电子邮件经过验证
